Wang Shu, Pan Junlin, Zhang Xiao, Li Yueying, Liu Wenxi, Lin Ruolan, Wang Xingfu, Kang Deyong, Li Zhijun, Huang Feng, Chen Liangyi, Chen Jianxin
School of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, 350108, China.
Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory of Photonics Technology, Fujian Normal University, Fuzhou, 350007, China.
Light Sci Appl. 2024 Sep 14;13(1):254. doi: 10.1038/s41377-024-01597-w.
Diagnostic pathology, historically dependent on visual scrutiny by experts, is essential for disease detection. Advances in digital pathology and developments in computer vision technology have led to the application of artificial intelligence (AI) in this field. Despite these advancements, the variability in pathologists' subjective interpretations of diagnostic criteria can lead to inconsistent outcomes. To meet the need for precision in cancer therapies, there is an increasing demand for accurate pathological diagnoses. Consequently, traditional diagnostic pathology is evolving towards "next-generation diagnostic pathology", prioritizing on the development of a multi-dimensional, intelligent diagnostic approach. Using nonlinear optical effects arising from the interaction of light with biological tissues, multiphoton microscopy (MPM) enables high-resolution label-free imaging of multiple intrinsic components across various human pathological tissues. AI-empowered MPM further improves the accuracy and efficiency of diagnosis, holding promise for providing auxiliary pathology diagnostic methods based on multiphoton diagnostic criteria. In this review, we systematically outline the applications of MPM in pathological diagnosis across various human diseases, and summarize common multiphoton diagnostic features. Moreover, we examine the significant role of AI in enhancing multiphoton pathological diagnosis, including aspects such as image preprocessing, refined differential diagnosis, and the prognostication of outcomes. We also discuss the challenges and perspectives faced by the integration of MPM and AI, encompassing equipment, datasets, analytical models, and integration into the existing clinical pathways. Finally, the review explores the synergy between AI and label-free MPM to forge novel diagnostic frameworks, aiming to accelerate the adoption and implementation of intelligent multiphoton pathology systems in clinical settings.
诊断病理学在历史上依赖专家的视觉检查,对疾病检测至关重要。数字病理学的进展和计算机视觉技术的发展促使人工智能(AI)在该领域的应用。尽管有这些进步,但病理学家对诊断标准的主观解释存在差异,可能导致结果不一致。为满足癌症治疗精准性的需求,对准确病理诊断的需求日益增加。因此,传统诊断病理学正在向“下一代诊断病理学”发展,重点是开发多维智能诊断方法。利用光与生物组织相互作用产生的非线性光学效应,多光子显微镜(MPM)能够对各种人类病理组织中的多种内在成分进行高分辨率无标记成像。人工智能赋能的MPM进一步提高了诊断的准确性和效率,有望基于多光子诊断标准提供辅助病理诊断方法。在本综述中,我们系统地概述了MPM在各种人类疾病病理诊断中的应用,并总结了常见的多光子诊断特征。此外,我们研究了人工智能在增强多光子病理诊断中的重要作用,包括图像预处理、精细鉴别诊断和结果预后等方面。我们还讨论了MPM与人工智能整合面临的挑战和前景,包括设备、数据集、分析模型以及融入现有临床路径等方面。最后,本综述探讨了人工智能与无标记MPM之间的协同作用,以构建新的诊断框架,旨在加速智能多光子病理系统在临床环境中的采用和实施。